Literature DB >> 29556571

Impact of care disparities in radiation oncology.

Tasneem Kaleem1, Grace Li Smith2, Robert C Miller1.   

Abstract

Entities:  

Year:  2017        PMID: 29556571      PMCID: PMC5856986          DOI: 10.1016/j.adro.2017.09.003

Source DB:  PubMed          Journal:  Adv Radiat Oncol        ISSN: 2452-1094


× No keyword cloud information.
Disparities have a multifaceted impact in the field of oncology with adverse differences in cancer outcomes, such as mortality, morbidity, and prevalence, that often translate into health inequities. The contemporary understanding of disparities has expanded beyond describing racial differences and toward explaining inequities by sex, age, income, education level, geographic location, insurance coverage, lifestyle, and cultural differences. Nevertheless, even these categorizations are fluid, in that they can still be imprecise, overlapping, interrelated, and/or synergistic, representing complex relationships between sociological, biological, structural, and even policy concepts. Studies of patients with cancer highlight the associations between barriers to quality cancer care and adverse cancer outcomes, positing influences by patient, structural, socioeconomic, and healthcare access risk factors.2, 3 There is some evidence to suggest that disparities may have a unique impact in the field of radiation oncology, with differences in patient utilization of advanced radiation technologies and access to high-volume facilities.3, 4, 5 Distance from radiation facilities is a well-known risk factor for inadequate radiation oncology care.6, 7, 8, 9 Disparities in radiation treatment delivery measures, including treatment delays, breaks, and incompletion, have also been documented,10, 11 along with the uptake of newer, benchmarked practices, such as hypofractionation in early stage breast cancer. The risk factors, mechanisms, and outcomes of disparities in radiation oncology still require additional investigations to prompt continuous improvements in multidisciplinary cancer care infrastructure and outcomes in the United States and beyond. We seek to highlight this topic with an ongoing series of articles on the impact of disparities on delivery and outcomes of radiation therapy as well as participation in research.
  10 in total

1.  Impact of facility volume on therapy and survival for locally advanced cervical cancer.

Authors:  Jeff F Lin; Jessica L Berger; Thomas C Krivak; Sushil Beriwal; John K Chan; Paniti Sukumvanich; Bradley J Monk; Scott D Richard
Journal:  Gynecol Oncol       Date:  2013-12-12       Impact factor: 5.482

Review 2.  Inequity in cancer care: explanations and solutions for disparity.

Authors:  Michael L Steinberg
Journal:  Semin Radiat Oncol       Date:  2008-07       Impact factor: 5.934

3.  Geographic Disparity in the Use of Hypofractionated Radiation Therapy Among Elderly Women Undergoing Breast Conservation for Invasive Breast Cancer.

Authors:  Erin F Gillespie; Rayna K Matsuno; Beibei Xu; Daniel P Triplett; Lindsay Hwang; Isabel J Boero; John P Einck; Catheryn Yashar; James D Murphy
Journal:  Int J Radiat Oncol Biol Phys       Date:  2016-05-12       Impact factor: 7.038

Review 4.  Variations in breast cancer treatment by patient and provider characteristics.

Authors:  J Z Ayanian; E Guadagnoli
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

5.  Patients Selected for Definitive Concurrent Chemoradiation at High-volume Facilities Achieve Improved Survival in Stage III Non-Small-Cell Lung Cancer.

Authors:  Elyn H Wang; Charles E Rutter; Christopher D Corso; Roy H Decker; Lynn D Wilson; Anthony W Kim; James B Yu; Henry S Park
Journal:  J Thorac Oncol       Date:  2015-06       Impact factor: 15.609

6.  Health disparity: time delay in the treatment of breast cancer in Louisiana.

Authors:  Riaz Ferdaus; Min Su Kim; James S Larson
Journal:  J Health Hum Serv Adm       Date:  2011

7.  Association Between Treatment at a High-Volume Facility and Improved Survival for Radiation-Treated Men With High-Risk Prostate Cancer.

Authors:  Yu-Wei Chen; Brandon A Mahal; Vinayak Muralidhar; Michelle Nezolosky; Clair J Beard; Robert B Den; Felix Y Feng; Karen E Hoffman; Neil E Martin; Peter F Orio; Paul L Nguyen
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-12-14       Impact factor: 7.038

8.  Provider case volume and outcomes following prostate brachytherapy.

Authors:  Aileen B Chen; Anthony V D'Amico; Bridget A Neville; Ewout W Steyerberg; Craig C Earle
Journal:  J Urol       Date:  2008-11-13       Impact factor: 7.450

9.  Impact of Insurance Status on Radiation Treatment Modality Selection Among Potential Candidates for Prostate, Breast, or Gynecologic Brachytherapy.

Authors:  Stephen R Grant; Gary V Walker; Matthew Koshy; Simona F Shaitelman; Ann H Klopp; Steven J Frank; Thomas J Pugh; Pamela K Allen; Usama Mahmood
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-08-28       Impact factor: 7.038

10.  Charting the Future of Cancer Health Disparities Research: A Position Statement From the American Association for Cancer Research, the American Cancer Society, the American Society of Clinical Oncology, and the National Cancer Institute.

Authors:  Blase N Polite; Lucile L Adams-Campbell; Otis W Brawley; Nina Bickell; John M Carethers; Christopher R Flowers; Margaret Foti; Scarlett Lin Gomez; Jennifer J Griggs; Christopher S Lathan; Christopher I Li; J Leonard Lichtenfeld; Worta McCaskill-Stevens; Electra D Paskett
Journal:  J Clin Oncol       Date:  2017-07-24       Impact factor: 44.544

  10 in total
  2 in total

1.  Socioeconomic inequality and omission of adjuvant radiation therapy in high-risk, early-stage endometrial cancer.

Authors:  Leo Y Luo; Emeline M Aviki; Anna Lee; Marisa A Kollmeier; Nadeem R Abu-Rustum; C Jillian Tsai; Kaled M Alektiar
Journal:  Gynecol Oncol       Date:  2021-02-15       Impact factor: 5.482

2.  Lessons From COVID-19: Addressing Health Equity in Cancer Care.

Authors:  Malika L Siker; Curtiland Deville; Gita Suneja; Karen Winkfield
Journal:  Int J Radiat Oncol Biol Phys       Date:  2020-10-01       Impact factor: 7.038

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.